Global SARS-CoV-2 genomic surveillance efforts have provided critical data on the ongoing
evolution of the virus to inform best practices in clinical care and public health throughout the …

Although many laboratories worldwide have developed their sequencing capacities in
response to the need for SARS-CoV-2 genome-based surveillance of variants, only a few …

Neonatal COVID-19 is rare and mainly results from postnatal transmission. Severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), however, can infect the placenta and …

Background Whole genome sequencing analyzed by core genome multi-locus sequence
typing (cgMLST) is widely used in surveillance of the pathogenic bacteria Listeria …

Background It is estimated that up to 80% of infections caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) are asymptomatic and asymptomatic patients can …

Rapid and recurrent breakthroughs of new SARS-CoV-2 strains (variants) have prompted
public health authorities worldwide to set up surveillance networks to monitor the circulation …

The molecular detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
is key for clinical management and surveillance. Funded by the European Centre for …

Abstract Background Puerto Rico has experienced the full impact of the COVID-19
pandemic. Since SARS-CoV-2, the virus that causes COVID-19, was first detected on the …

Almost a year after the COVID-19 pandemic had begun, new lineages (B. 1.1. 7, B. 1.351, P.
1, and B. 1.617. 2) associated with enhanced transmissibility, immunity evasion, and …

The severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) is the
etiopathogenic agent of COVID-19, a condition that has led to a formally recognized …